nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Vismodegib—skin cancer	0.329	0.557	CbGbCtD
Mannitol—ABCB1—Dactinomycin—skin cancer	0.173	0.292	CbGbCtD
Mannitol—ABCB1—Docetaxel—skin cancer	0.0891	0.151	CbGbCtD
Mannitol—Mental disorder—Imiquimod—skin cancer	0.00129	0.00314	CcSEcCtD
Mannitol—Bronchospasm—Bleomycin—skin cancer	0.00128	0.00313	CcSEcCtD
Mannitol—Oropharyngeal pain—Docetaxel—skin cancer	0.00128	0.00313	CcSEcCtD
Mannitol—Malnutrition—Imiquimod—skin cancer	0.00128	0.00312	CcSEcCtD
Mannitol—Arthralgia—Vemurafenib—skin cancer	0.00128	0.00312	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00127	0.00309	CcSEcCtD
Mannitol—Vomiting—Vismodegib—skin cancer	0.00126	0.00307	CcSEcCtD
Mannitol—Rash—Vismodegib—skin cancer	0.00125	0.00305	CcSEcCtD
Mannitol—Dermatitis—Vismodegib—skin cancer	0.00125	0.00305	CcSEcCtD
Mannitol—Back pain—Imiquimod—skin cancer	0.00124	0.00302	CcSEcCtD
Mannitol—Infection—Vemurafenib—skin cancer	0.00122	0.00297	CcSEcCtD
Mannitol—Cardiac failure—Fluorouracil—skin cancer	0.0012	0.00293	CcSEcCtD
Mannitol—Nervous system disorder—Vemurafenib—skin cancer	0.0012	0.00293	CcSEcCtD
Mannitol—Skin disorder—Vemurafenib—skin cancer	0.00119	0.0029	CcSEcCtD
Mannitol—Ill-defined disorder—Imiquimod—skin cancer	0.00119	0.0029	CcSEcCtD
Mannitol—Dehydration—Temozolomide—skin cancer	0.00118	0.00289	CcSEcCtD
Mannitol—Nausea—Vismodegib—skin cancer	0.00118	0.00287	CcSEcCtD
Mannitol—Malaise—Imiquimod—skin cancer	0.00115	0.00281	CcSEcCtD
Mannitol—Hypotension—Vemurafenib—skin cancer	0.00114	0.00279	CcSEcCtD
Mannitol—Stomatitis—Bleomycin—skin cancer	0.00113	0.00277	CcSEcCtD
Mannitol—Influenza like illness—Docetaxel—skin cancer	0.00113	0.00276	CcSEcCtD
Mannitol—Cough—Imiquimod—skin cancer	0.00112	0.00272	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00111	0.00272	CcSEcCtD
Mannitol—Candida infection—Docetaxel—skin cancer	0.00111	0.00272	CcSEcCtD
Mannitol—Skin exfoliation—Docetaxel—skin cancer	0.00111	0.00272	CcSEcCtD
Mannitol—Convulsion—Imiquimod—skin cancer	0.00111	0.0027	CcSEcCtD
Mannitol—Hypertension—Imiquimod—skin cancer	0.0011	0.00269	CcSEcCtD
Mannitol—Arthralgia—Imiquimod—skin cancer	0.00109	0.00266	CcSEcCtD
Mannitol—Chest pain—Imiquimod—skin cancer	0.00109	0.00266	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00108	0.00264	CcSEcCtD
Mannitol—Discomfort—Imiquimod—skin cancer	0.00108	0.00263	CcSEcCtD
Mannitol—Decreased appetite—Vemurafenib—skin cancer	0.00106	0.0026	CcSEcCtD
Mannitol—Bronchitis—Temozolomide—skin cancer	0.00106	0.00258	CcSEcCtD
Mannitol—Stomatitis—Dactinomycin—skin cancer	0.00106	0.00258	CcSEcCtD
Mannitol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00106	0.00258	CcSEcCtD
Mannitol—Fatigue—Vemurafenib—skin cancer	0.00105	0.00257	CcSEcCtD
Mannitol—Nasopharyngitis—Fluorouracil—skin cancer	0.00105	0.00256	CcSEcCtD
Mannitol—Oedema—Imiquimod—skin cancer	0.00104	0.00255	CcSEcCtD
Mannitol—Pulmonary oedema—Docetaxel—skin cancer	0.00104	0.00253	CcSEcCtD
Mannitol—Infection—Imiquimod—skin cancer	0.00104	0.00253	CcSEcCtD
Mannitol—Nervous system disorder—Imiquimod—skin cancer	0.00102	0.0025	CcSEcCtD
Mannitol—Upper respiratory tract infection—Temozolomide—skin cancer	0.00102	0.00249	CcSEcCtD
Mannitol—Tachycardia—Imiquimod—skin cancer	0.00102	0.00249	CcSEcCtD
Mannitol—Skin disorder—Imiquimod—skin cancer	0.00101	0.00247	CcSEcCtD
Mannitol—Angina pectoris—Fluorouracil—skin cancer	0.000987	0.00241	CcSEcCtD
Mannitol—Phlebitis—Docetaxel—skin cancer	0.000982	0.0024	CcSEcCtD
Mannitol—Infestation NOS—Temozolomide—skin cancer	0.00098	0.00239	CcSEcCtD
Mannitol—Infestation—Temozolomide—skin cancer	0.00098	0.00239	CcSEcCtD
Mannitol—Thrombophlebitis—Docetaxel—skin cancer	0.000977	0.00239	CcSEcCtD
Mannitol—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000973	0.00237	CcSEcCtD
Mannitol—Body temperature increased—Vemurafenib—skin cancer	0.000967	0.00236	CcSEcCtD
Mannitol—Pharyngitis—Dactinomycin—skin cancer	0.000966	0.00236	CcSEcCtD
Mannitol—Stomatitis—Temozolomide—skin cancer	0.000956	0.00233	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000951	0.00232	CcSEcCtD
Mannitol—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000942	0.0023	CcSEcCtD
Mannitol—Chills—Bleomycin—skin cancer	0.000936	0.00229	CcSEcCtD
Mannitol—Cardiac failure congestive—Docetaxel—skin cancer	0.000933	0.00228	CcSEcCtD
Mannitol—Dyspnoea—Imiquimod—skin cancer	0.00093	0.00227	CcSEcCtD
Mannitol—Decreased appetite—Imiquimod—skin cancer	0.000907	0.00221	CcSEcCtD
Mannitol—Infestation—Fluorouracil—skin cancer	0.000903	0.00221	CcSEcCtD
Mannitol—Infestation NOS—Fluorouracil—skin cancer	0.000903	0.00221	CcSEcCtD
Mannitol—Hypersensitivity—Vemurafenib—skin cancer	0.000901	0.0022	CcSEcCtD
Mannitol—Gastrointestinal disorder—Imiquimod—skin cancer	0.000901	0.0022	CcSEcCtD
Mannitol—Fatigue—Imiquimod—skin cancer	0.0009	0.0022	CcSEcCtD
Mannitol—Pain—Imiquimod—skin cancer	0.000892	0.00218	CcSEcCtD
Mannitol—Stomatitis—Fluorouracil—skin cancer	0.00088	0.00215	CcSEcCtD
Mannitol—Asthenia—Vemurafenib—skin cancer	0.000878	0.00214	CcSEcCtD
Mannitol—Pharyngitis—Temozolomide—skin cancer	0.000874	0.00213	CcSEcCtD
Mannitol—Chills—Dactinomycin—skin cancer	0.000873	0.00213	CcSEcCtD
Mannitol—Urinary tract disorder—Temozolomide—skin cancer	0.000869	0.00212	CcSEcCtD
Mannitol—Cardiac failure—Docetaxel—skin cancer	0.000867	0.00212	CcSEcCtD
Mannitol—Pruritus—Vemurafenib—skin cancer	0.000866	0.00211	CcSEcCtD
Mannitol—Connective tissue disorder—Temozolomide—skin cancer	0.000865	0.00211	CcSEcCtD
Mannitol—Urethral disorder—Temozolomide—skin cancer	0.000863	0.00211	CcSEcCtD
Mannitol—Feeling abnormal—Imiquimod—skin cancer	0.00086	0.0021	CcSEcCtD
Mannitol—Hyponatraemia—Docetaxel—skin cancer	0.000849	0.00207	CcSEcCtD
Mannitol—Pain in extremity—Docetaxel—skin cancer	0.000846	0.00207	CcSEcCtD
Mannitol—Ill-defined disorder—Bleomycin—skin cancer	0.000843	0.00206	CcSEcCtD
Mannitol—Diarrhoea—Vemurafenib—skin cancer	0.000837	0.00204	CcSEcCtD
Mannitol—Urticaria—Imiquimod—skin cancer	0.000829	0.00202	CcSEcCtD
Mannitol—Body temperature increased—Imiquimod—skin cancer	0.000825	0.00201	CcSEcCtD
Mannitol—Malaise—Bleomycin—skin cancer	0.000819	0.002	CcSEcCtD
Mannitol—Rhinitis—Fluorouracil—skin cancer	0.000813	0.00198	CcSEcCtD
Mannitol—Dizziness—Vemurafenib—skin cancer	0.000809	0.00197	CcSEcCtD
Mannitol—Pharyngitis—Fluorouracil—skin cancer	0.000805	0.00196	CcSEcCtD
Mannitol—Mediastinal disorder—Temozolomide—skin cancer	0.000793	0.00194	CcSEcCtD
Mannitol—Cough—Bleomycin—skin cancer	0.000793	0.00193	CcSEcCtD
Mannitol—Chills—Temozolomide—skin cancer	0.00079	0.00193	CcSEcCtD
Mannitol—Dehydration—Docetaxel—skin cancer	0.000787	0.00192	CcSEcCtD
Mannitol—Ill-defined disorder—Dactinomycin—skin cancer	0.000786	0.00192	CcSEcCtD
Mannitol—Vomiting—Vemurafenib—skin cancer	0.000778	0.0019	CcSEcCtD
Mannitol—Chest pain—Bleomycin—skin cancer	0.000773	0.00189	CcSEcCtD
Mannitol—Abdominal pain upper—Docetaxel—skin cancer	0.000773	0.00189	CcSEcCtD
Mannitol—Rash—Vemurafenib—skin cancer	0.000771	0.00188	CcSEcCtD
Mannitol—Mental disorder—Temozolomide—skin cancer	0.000771	0.00188	CcSEcCtD
Mannitol—Dermatitis—Vemurafenib—skin cancer	0.000771	0.00188	CcSEcCtD
Mannitol—Hypersensitivity—Imiquimod—skin cancer	0.000769	0.00188	CcSEcCtD
Mannitol—Headache—Vemurafenib—skin cancer	0.000766	0.00187	CcSEcCtD
Mannitol—Malnutrition—Temozolomide—skin cancer	0.000766	0.00187	CcSEcCtD
Mannitol—Discomfort—Bleomycin—skin cancer	0.000764	0.00186	CcSEcCtD
Mannitol—Malaise—Dactinomycin—skin cancer	0.000764	0.00186	CcSEcCtD
Mannitol—Nasopharyngitis—Docetaxel—skin cancer	0.000757	0.00185	CcSEcCtD
Mannitol—Asthenia—Imiquimod—skin cancer	0.000749	0.00183	CcSEcCtD
Mannitol—Oedema—Bleomycin—skin cancer	0.000741	0.00181	CcSEcCtD
Mannitol—Back pain—Temozolomide—skin cancer	0.000741	0.00181	CcSEcCtD
Mannitol—Pruritus—Imiquimod—skin cancer	0.000738	0.0018	CcSEcCtD
Mannitol—Infection—Bleomycin—skin cancer	0.000736	0.0018	CcSEcCtD
Mannitol—Nausea—Vemurafenib—skin cancer	0.000727	0.00177	CcSEcCtD
Mannitol—Vision blurred—Temozolomide—skin cancer	0.000722	0.00176	CcSEcCtD
Mannitol—Bronchospasm—Docetaxel—skin cancer	0.000719	0.00176	CcSEcCtD
Mannitol—Diarrhoea—Imiquimod—skin cancer	0.000714	0.00174	CcSEcCtD
Mannitol—Discomfort—Dactinomycin—skin cancer	0.000713	0.00174	CcSEcCtD
Mannitol—Angina pectoris—Docetaxel—skin cancer	0.000712	0.00174	CcSEcCtD
Mannitol—Ill-defined disorder—Temozolomide—skin cancer	0.000711	0.00174	CcSEcCtD
Mannitol—Hypotension—Bleomycin—skin cancer	0.000693	0.00169	CcSEcCtD
Mannitol—Oedema—Dactinomycin—skin cancer	0.000691	0.00169	CcSEcCtD
Mannitol—Malaise—Temozolomide—skin cancer	0.000691	0.00169	CcSEcCtD
Mannitol—Dizziness—Imiquimod—skin cancer	0.00069	0.00168	CcSEcCtD
Mannitol—Vertigo—Temozolomide—skin cancer	0.000688	0.00168	CcSEcCtD
Mannitol—Infection—Dactinomycin—skin cancer	0.000687	0.00168	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000675	0.00165	CcSEcCtD
Mannitol—Cough—Temozolomide—skin cancer	0.000669	0.00163	CcSEcCtD
Mannitol—Vision blurred—Fluorouracil—skin cancer	0.000665	0.00162	CcSEcCtD
Mannitol—Convulsion—Temozolomide—skin cancer	0.000664	0.00162	CcSEcCtD
Mannitol—Vomiting—Imiquimod—skin cancer	0.000663	0.00162	CcSEcCtD
Mannitol—Hypertension—Temozolomide—skin cancer	0.000661	0.00161	CcSEcCtD
Mannitol—Dyspnoea—Bleomycin—skin cancer	0.000661	0.00161	CcSEcCtD
Mannitol—Rash—Imiquimod—skin cancer	0.000658	0.00161	CcSEcCtD
Mannitol—Dermatitis—Imiquimod—skin cancer	0.000657	0.0016	CcSEcCtD
Mannitol—Headache—Imiquimod—skin cancer	0.000654	0.0016	CcSEcCtD
Mannitol—Arthralgia—Temozolomide—skin cancer	0.000652	0.00159	CcSEcCtD
Mannitol—Infestation NOS—Docetaxel—skin cancer	0.000652	0.00159	CcSEcCtD
Mannitol—Infestation—Docetaxel—skin cancer	0.000652	0.00159	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000648	0.00158	CcSEcCtD
Mannitol—Discomfort—Temozolomide—skin cancer	0.000644	0.00157	CcSEcCtD
Mannitol—Decreased appetite—Bleomycin—skin cancer	0.000644	0.00157	CcSEcCtD
Mannitol—Renal failure—Docetaxel—skin cancer	0.000641	0.00156	CcSEcCtD
Mannitol—Stomatitis—Docetaxel—skin cancer	0.000636	0.00155	CcSEcCtD
Mannitol—Pain—Bleomycin—skin cancer	0.000634	0.00155	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00063	0.00154	CcSEcCtD
Mannitol—Oedema—Temozolomide—skin cancer	0.000625	0.00153	CcSEcCtD
Mannitol—Infection—Temozolomide—skin cancer	0.000621	0.00152	CcSEcCtD
Mannitol—Nausea—Imiquimod—skin cancer	0.00062	0.00151	CcSEcCtD
Mannitol—Nervous system disorder—Temozolomide—skin cancer	0.000613	0.0015	CcSEcCtD
Mannitol—Convulsion—Fluorouracil—skin cancer	0.000612	0.00149	CcSEcCtD
Mannitol—Feeling abnormal—Bleomycin—skin cancer	0.000611	0.00149	CcSEcCtD
Mannitol—Skin disorder—Temozolomide—skin cancer	0.000607	0.00148	CcSEcCtD
Mannitol—Chest pain—Fluorouracil—skin cancer	0.000601	0.00147	CcSEcCtD
Mannitol—Decreased appetite—Dactinomycin—skin cancer	0.000601	0.00147	CcSEcCtD
Mannitol—Fatigue—Dactinomycin—skin cancer	0.000596	0.00145	CcSEcCtD
Mannitol—Discomfort—Fluorouracil—skin cancer	0.000594	0.00145	CcSEcCtD
Mannitol—Pain—Dactinomycin—skin cancer	0.000591	0.00144	CcSEcCtD
Mannitol—Urticaria—Bleomycin—skin cancer	0.000589	0.00144	CcSEcCtD
Mannitol—Rhinitis—Docetaxel—skin cancer	0.000587	0.00143	CcSEcCtD
Mannitol—Body temperature increased—Bleomycin—skin cancer	0.000586	0.00143	CcSEcCtD
Mannitol—Pharyngitis—Docetaxel—skin cancer	0.000581	0.00142	CcSEcCtD
Mannitol—Urinary tract disorder—Docetaxel—skin cancer	0.000578	0.00141	CcSEcCtD
Mannitol—Oedema—Fluorouracil—skin cancer	0.000576	0.00141	CcSEcCtD
Mannitol—Connective tissue disorder—Docetaxel—skin cancer	0.000575	0.0014	CcSEcCtD
Mannitol—Urethral disorder—Docetaxel—skin cancer	0.000574	0.0014	CcSEcCtD
Mannitol—Infection—Fluorouracil—skin cancer	0.000572	0.0014	CcSEcCtD
Mannitol—Feeling abnormal—Dactinomycin—skin cancer	0.00057	0.00139	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00057	0.00139	CcSEcCtD
Mannitol—Nervous system disorder—Fluorouracil—skin cancer	0.000565	0.00138	CcSEcCtD
Mannitol—Tachycardia—Fluorouracil—skin cancer	0.000562	0.00137	CcSEcCtD
Mannitol—Dyspnoea—Temozolomide—skin cancer	0.000557	0.00136	CcSEcCtD
Mannitol—Body temperature increased—Dactinomycin—skin cancer	0.000547	0.00133	CcSEcCtD
Mannitol—Hypersensitivity—Bleomycin—skin cancer	0.000546	0.00133	CcSEcCtD
Mannitol—Decreased appetite—Temozolomide—skin cancer	0.000544	0.00133	CcSEcCtD
Mannitol—Gastrointestinal disorder—Temozolomide—skin cancer	0.00054	0.00132	CcSEcCtD
Mannitol—Fatigue—Temozolomide—skin cancer	0.000539	0.00132	CcSEcCtD
Mannitol—Hypotension—Fluorouracil—skin cancer	0.000538	0.00131	CcSEcCtD
Mannitol—Pain—Temozolomide—skin cancer	0.000535	0.00131	CcSEcCtD
Mannitol—Asthenia—Bleomycin—skin cancer	0.000532	0.0013	CcSEcCtD
Mannitol—Mediastinal disorder—Docetaxel—skin cancer	0.000527	0.00129	CcSEcCtD
Mannitol—Chills—Docetaxel—skin cancer	0.000525	0.00128	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000525	0.00128	CcSEcCtD
Mannitol—Pruritus—Bleomycin—skin cancer	0.000524	0.00128	CcSEcCtD
Mannitol—Feeling abnormal—Temozolomide—skin cancer	0.000515	0.00126	CcSEcCtD
Mannitol—Dyspnoea—Fluorouracil—skin cancer	0.000514	0.00125	CcSEcCtD
Mannitol—Mental disorder—Docetaxel—skin cancer	0.000513	0.00125	CcSEcCtD
Mannitol—Malnutrition—Docetaxel—skin cancer	0.000509	0.00124	CcSEcCtD
Mannitol—Hypersensitivity—Dactinomycin—skin cancer	0.000509	0.00124	CcSEcCtD
Mannitol—Decreased appetite—Fluorouracil—skin cancer	0.000501	0.00122	CcSEcCtD
Mannitol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000497	0.00121	CcSEcCtD
Mannitol—Urticaria—Temozolomide—skin cancer	0.000497	0.00121	CcSEcCtD
Mannitol—Asthenia—Dactinomycin—skin cancer	0.000496	0.00121	CcSEcCtD
Mannitol—Body temperature increased—Temozolomide—skin cancer	0.000494	0.00121	CcSEcCtD
Mannitol—Back pain—Docetaxel—skin cancer	0.000493	0.0012	CcSEcCtD
Mannitol—Pain—Fluorouracil—skin cancer	0.000493	0.0012	CcSEcCtD
Mannitol—Feeling abnormal—Fluorouracil—skin cancer	0.000475	0.00116	CcSEcCtD
Mannitol—Diarrhoea—Dactinomycin—skin cancer	0.000473	0.00115	CcSEcCtD
Mannitol—Vomiting—Bleomycin—skin cancer	0.000471	0.00115	CcSEcCtD
Mannitol—Rash—Bleomycin—skin cancer	0.000467	0.00114	CcSEcCtD
Mannitol—Dermatitis—Bleomycin—skin cancer	0.000467	0.00114	CcSEcCtD
Mannitol—Hypersensitivity—Temozolomide—skin cancer	0.000461	0.00112	CcSEcCtD
Mannitol—Urticaria—Fluorouracil—skin cancer	0.000458	0.00112	CcSEcCtD
Mannitol—Body temperature increased—Fluorouracil—skin cancer	0.000455	0.00111	CcSEcCtD
Mannitol—Asthenia—Temozolomide—skin cancer	0.000449	0.0011	CcSEcCtD
Mannitol—Cough—Docetaxel—skin cancer	0.000445	0.00109	CcSEcCtD
Mannitol—Pruritus—Temozolomide—skin cancer	0.000442	0.00108	CcSEcCtD
Mannitol—Convulsion—Docetaxel—skin cancer	0.000441	0.00108	CcSEcCtD
Mannitol—Nausea—Bleomycin—skin cancer	0.00044	0.00107	CcSEcCtD
Mannitol—Hypertension—Docetaxel—skin cancer	0.00044	0.00107	CcSEcCtD
Mannitol—Vomiting—Dactinomycin—skin cancer	0.00044	0.00107	CcSEcCtD
Mannitol—Rash—Dactinomycin—skin cancer	0.000436	0.00106	CcSEcCtD
Mannitol—Arthralgia—Docetaxel—skin cancer	0.000434	0.00106	CcSEcCtD
Mannitol—Chest pain—Docetaxel—skin cancer	0.000434	0.00106	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000431	0.00105	CcSEcCtD
Mannitol—Diarrhoea—Temozolomide—skin cancer	0.000428	0.00104	CcSEcCtD
Mannitol—Hypersensitivity—Fluorouracil—skin cancer	0.000424	0.00104	CcSEcCtD
Mannitol—Oedema—Docetaxel—skin cancer	0.000416	0.00102	CcSEcCtD
Mannitol—Dizziness—Temozolomide—skin cancer	0.000413	0.00101	CcSEcCtD
Mannitol—Infection—Docetaxel—skin cancer	0.000413	0.00101	CcSEcCtD
Mannitol—Nausea—Dactinomycin—skin cancer	0.000411	0.001	CcSEcCtD
Mannitol—Nervous system disorder—Docetaxel—skin cancer	0.000408	0.000995	CcSEcCtD
Mannitol—Pruritus—Fluorouracil—skin cancer	0.000408	0.000995	CcSEcCtD
Mannitol—Tachycardia—Docetaxel—skin cancer	0.000406	0.000991	CcSEcCtD
Mannitol—Skin disorder—Docetaxel—skin cancer	0.000404	0.000986	CcSEcCtD
Mannitol—Vomiting—Temozolomide—skin cancer	0.000398	0.00097	CcSEcCtD
Mannitol—Rash—Temozolomide—skin cancer	0.000394	0.000962	CcSEcCtD
Mannitol—Diarrhoea—Fluorouracil—skin cancer	0.000394	0.000962	CcSEcCtD
Mannitol—Dermatitis—Temozolomide—skin cancer	0.000394	0.000961	CcSEcCtD
Mannitol—Headache—Temozolomide—skin cancer	0.000392	0.000956	CcSEcCtD
Mannitol—Hypotension—Docetaxel—skin cancer	0.000389	0.000948	CcSEcCtD
Mannitol—Dizziness—Fluorouracil—skin cancer	0.000381	0.00093	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000379	0.000925	CcSEcCtD
Mannitol—Nausea—Temozolomide—skin cancer	0.000371	0.000907	CcSEcCtD
Mannitol—Dyspnoea—Docetaxel—skin cancer	0.000371	0.000905	CcSEcCtD
Mannitol—Vomiting—Fluorouracil—skin cancer	0.000366	0.000894	CcSEcCtD
Mannitol—Rash—Fluorouracil—skin cancer	0.000363	0.000887	CcSEcCtD
Mannitol—Dermatitis—Fluorouracil—skin cancer	0.000363	0.000886	CcSEcCtD
Mannitol—Decreased appetite—Docetaxel—skin cancer	0.000361	0.000882	CcSEcCtD
Mannitol—Headache—Fluorouracil—skin cancer	0.000361	0.000881	CcSEcCtD
Mannitol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000359	0.000876	CcSEcCtD
Mannitol—Fatigue—Docetaxel—skin cancer	0.000359	0.000875	CcSEcCtD
Mannitol—Pain—Docetaxel—skin cancer	0.000356	0.000868	CcSEcCtD
Mannitol—Feeling abnormal—Docetaxel—skin cancer	0.000343	0.000836	CcSEcCtD
Mannitol—Nausea—Fluorouracil—skin cancer	0.000342	0.000835	CcSEcCtD
Mannitol—Body temperature increased—Docetaxel—skin cancer	0.000329	0.000802	CcSEcCtD
Mannitol—Hypersensitivity—Docetaxel—skin cancer	0.000306	0.000748	CcSEcCtD
Mannitol—Asthenia—Docetaxel—skin cancer	0.000298	0.000728	CcSEcCtD
Mannitol—Pruritus—Docetaxel—skin cancer	0.000294	0.000718	CcSEcCtD
Mannitol—Diarrhoea—Docetaxel—skin cancer	0.000285	0.000694	CcSEcCtD
Mannitol—Dizziness—Docetaxel—skin cancer	0.000275	0.000671	CcSEcCtD
Mannitol—Vomiting—Docetaxel—skin cancer	0.000264	0.000645	CcSEcCtD
Mannitol—Rash—Docetaxel—skin cancer	0.000262	0.00064	CcSEcCtD
Mannitol—Dermatitis—Docetaxel—skin cancer	0.000262	0.000639	CcSEcCtD
Mannitol—Headache—Docetaxel—skin cancer	0.00026	0.000636	CcSEcCtD
Mannitol—Nausea—Docetaxel—skin cancer	0.000247	0.000603	CcSEcCtD
